Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth

Journal of Hypertension

Volumn 16, Issue 3, 1998, Pages 377-384

  Grohé, Christian ^a,c   Kahlert, Stefan ^a   Löbbert, Kerstin ^a   Neyses, Ludwig ^b   Van Eickels, Martin ^a   Stimpel, Michael ^a   Vetter, Hans ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Angiotensin II; c fos; Cardiac fibroblasts; Estrogen; Moexiprilat; Sp 1

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; BROXURIDINE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTRADIOL; ESTROGEN; ESTRONE; MOEXIPRILAT; ANGIOTENSIN II; ISOQUINOLINE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; ESTROGEN BLOOD LEVEL; FETAL CALF SERUM; FIBROBLAST; GENE EXPRESSION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HYPERTENSION; IMMUNOBLOTTING; MENOPAUSE; NEWBORN; NONHUMAN; ONCOGENE C FOS; POSTMENOPAUSE; PRIORITY JOURNAL; RAT; TIME; ANIMAL; CELL CULTURE; CELL DIVISION; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; FEMALE; GENETICS; HEART; HEART MUSCLE; HUMAN; MALE; METABOLISM; ONCOGENE; PATHOLOGY;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA; ENDOMYOCARDIAL FIBROSIS; ESTRADIOL; ESTRONE; FEMALE; FIBROBLASTS; GENE EXPRESSION; GENES, FOS; HEART; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; ISOQUINOLINES; MALE; MENOPAUSE; MYOCARDIUM; RATS; SP1 TRANSCRIPTION FACTOR; TETRAHYDROISOQUINOLINES;

EID: 0031596620     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816030-00015     Document Type: Article

References (32)

1. Cacciabaudo JM, Sealey JE. Hormone replacement therapy and hypertension: relationship to the renin-angiotensin system. In: Safar M, Zanchetti M (editors). Hypertension in postmenopausal women. New York: Springer; 1992. pp. 53-61.
2. Schunkert H, Danser AHJ, Hense HW, Derkx FHM, Kürzinger S, Riegger GAJ. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997; 95:39-45.
3. Feldmer M, Kalling M, Takahashi S, Mullins JJ, Ganten D. Glucocorticoidand estrogen-responsive elements in the 5′ flanking region of the rat angiotensinogen gene. J Hypertens 1991; 9:1005-1012.
4. Schatzkin A, Cupples LC, Heeren T, Morelock S, Kannel WB. Sudden death in the Framingham Heart Study. Differences in incidence and risk factors by sex and coronary disease status. Am J Epidemiol 1984; 120:888-899.
5. Marcus R, Krause L, Weder AB, Dominguez-Mejia A, Schork NJ, Julius S. Sex-specific determinants of increased ventricular mass in the Tecumseh Blood Pressure Study. Circulation 1994; 90:928-933.
6. Dahlberg ST, Gender difference in the risk factors for sudden cardiac death. Cardiology 1990; 77:31-36.
7. Proudler AJ, Ahmed AH, Crook D, Fogelman I, Rymer JM, Stevenson JC. Hormone replacement therapy and serum angiotensin-enzyme activity in postmenopausal women. Lancet 1995; 346:89-90.
8. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. Am J Hypertens 1992; 5:95-99.
9. White WB, Fox AA, Stimpel M. Long-term efficiency and safety of moexipril in the treatment of hypertension. J Hum Hypertens 1994; 8:917-921.
10. Lorell BH. ACE inhibitors after myocardial infarction. N Engl J Med 1993; 328:966-967.
11. Grohé C, Briesemeister G, Stimpel M, Karas RH, Vetter H, Neyses L. Functional estrogen receptors in myocardial and myogenic cells. Circulation 1994; 90:2898.
12. Kahlert S, Grohé C, Karas RH, Löbbert K, Neyses L, Vetter H. Effects of estrogen on skeletal myoblast growth. Biophys Biochem Res Commun 1997; 232:373-378.
13. Grohé C, Kahlert S, Löbbert K, Myer R, Linz K, Karas RH, et al. Modulation of hypertensive heart disease by estrogen. Steroids 1996; 61:201-204.
14. Grohé C, Kahlert S, Löbbert K, van Eickels M, Stimpel M, Vetter H, et al. Effects of moexiprilat on estrogen-stimulated cardiac fibroblast growth. Br J Pharm 1997; 121:1350-1354.
15. Simpson P, Savion S. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Circ Res 1982; 50:101-116.
16. Weber KT, Sun Y, Katwa LC, Cleutjens JP, Zhou G. Connective tissue and repair in the heart: potential regulatory mechanisms. Ann NY Acad Sci 1995; 752:286-298.
17. Crawford DC, Chobanian AV, Brecher P, Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res 1994; 74:727-739.
18. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990; 67:1355-1361.
19. Villarreal FJ, Kim NN, Gilanthony D, Ungab BS, Printz MP, Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circ Res 1993; 88:2549-2556.
20. Schorb W, Booz GW, Dostal DE, Conrad KM, Chang KC, Baker KM. Angiotensin II is mitogenic in neonatal cardiac fibroblasts. Circ Res 1993; 72:1245-1254.
21. Stauss HM, Zhu YC, Redlich T, Adamiak D, Mott A, Kregel KC, et al. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II. J Cardiovasc Risk 1995; 3:255-260.
22. Kalenga KM, De Gasparo M, Thomas K, De Hertogh R. Angiotensin-II stimulates estradiol secretion from human placental explants through AT, receptor activation. J Clin Endocrinol Metab 1995; 80:1233-1237.
23. Neyses L, Nouskas J, Luyken J, Fronhoffs S, Oberdorf S, Pfeifer U, et al. Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes. 1993; 11:927-931.
24. Cicatiello L, Sica V, Breciani F, Weisz A, Identification of a specific pattern of 'immediate-early' gene activation induced by estrogen during mitogenic stimulation of rat uterine cells. Receptor 1993; 3:17-30.
25. Hyder SM, Stencel GM, In vitro interaction of uterine estrogen receptor with the response element present in the 3′ flanking region of the murine c-fos protooncogene. J Steroid Biochem Mol Biol 1994; 48:69-79.
26. Udvadia AJ, Rogers KT, Higgins PDR, Murata Y, Martin KH, Humphrey PA, et al. Sp-1 binds promoter elements regulated by the RB protein and Sp-1 mediated transcription is stimulated by RB expression. Proc Natl Acad Sci USA 1993; 90:3265-3269.
27. Skerka C, Decker EL, Zipfel PF. A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger protein Sp-1 and egr-1. J Biol Chem 1995; 270:22500-25006.
28. Brilla CG, Matsubara L, Weber KT. Advanced hypertensive heart disease in spontaneously hypertensive rats. Hypertension 1996; 28:269-275.
29. Gottdiener JS, Reda DJ, Massie BM, Materson BJ, Williams DW, Anderson RJ. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension. Circulation 1997; 95:2007-2014.
30. Devereux R. Do antihypertensive drugs differ in their ability to regress left ventricular hypertrophy? Circulation 1997; 95:1983-1985.
31. Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: meta analysis of randomized double-blind studies. JAMA 1996; 275:1507-1513.
32. Agabiti-Rosei E, Ambrosioni E, dal Palu C, Muiesen ML, Zanchetti A, on behalf of the RACE Study Group. ACE inhibitor ramipril is more effective than beta-blocker atenolol in reducing left ventricular hypertrophy in hypertension: results of the RACE (Ramipril Cardioprotective Evaluation) study. J Hypertens 1995; 13:1325-1334.